TP73 and triple-negative breast carcinoma: Recent post-2020 transcriptomic studies, including the EMBER platform [23], profiling of triple-negative inflammatory breast cancer, Indian breast cancer transcriptomics [24], multi-country Latin American cohorts [25], and spatial transcriptomics of triple-negative breast cancer [26], further highlight the importance of transcriptomic context in interpreting p73 function and subtype-specific biology.